Skip to main content

News

By Jessica Hagen | 11:32 am | March 21, 2023
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
By Adam Ang | 03:56 am | March 21, 2023
The antiviral medication was found to interact with over 2,000 prescription drugs.
By Jessica Hagen | 03:25 pm | March 20, 2023
The collaboration will expand MedArrive's maternal care services for managed Medicaid health plan members.
By Jessica Hagen | 11:05 am | March 20, 2023
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.
By Adam Ang | 08:18 am | March 20, 2023
AI will be integrated to increase pathologists' efficiency.
By Adam Ang | 03:23 am | March 20, 2023
There could be drug misuse and adverse side effects and drug interactions with mobile app prescribing.
By Adam Ang | 03:17 am | March 20, 2023
VC funding in the world's second-biggest digital health ecosystem decreased by 41% year-on-year.
By Emily Olsen | 03:50 pm | March 17, 2023
Without a transaction, the prescription digital therapeutics company said it may need to reorganize or liquidate.
By Emily Olsen | 12:55 pm | March 17, 2023
Zus also announced a partnership with primary care tech company Elation Health.
By Jessica Hagen | 11:24 am | March 17, 2023
The company also announced a new payer network and revenue cycle management service.